Company profile: Anbio
1.1 - Company Overview
Company description
- Provider of in vitro diagnostic medical devices and solutions, developing and manufacturing laboratory, at-home, and point-of-care tests for cancer, cardiovascular diseases, infectious diseases, and pharmacogenomics; conducts research and provides diagnosis globally.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Anbio
Streck
HQ: United States
Website
- Description: Provider of biotechnology, control and diagnostic products for clinical laboratories, hospitals, and clinicians, including clinical controls and QC devices across hematology, immunology, flow cytometry, chemistry, and urinalysis to support validation and quality assurance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Streck company profile →
CTI Molecular Imaging
HQ: United States
Website
- Description: Provider of imaging solutions for the healthcare industry; CTI Molecular Imaging was acquired and now operates as Siemens Molecular Imaging, a subsidiary of Siemens Medical Solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CTI Molecular Imaging company profile →
Myconostica
HQ: United Kingdom
Website
- Description: Provider of molecular diagnostic products to aid rapid and accurate diagnosis of life-threatening invasive fungal infections, addressing the relative insensitivity and slowness of traditional culture and microscopy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Myconostica company profile →
BioPorto
HQ: Denmark
Website
- Description: Provider of in-vitro diagnostic products, offering a range of diagnostic tests and antibodies to healthcare professionals in clinical and research settings. Portfolio includes assays for underserved disease states, such as NGAL for acute kidney injury.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioPorto company profile →
Flagship Biosciences
HQ: United States
Website
- Description: Provider of AI-enabled tissue profiling via the cTA pathology platform, offering SPATIALPlex spatial biology, Flagship Data Science for per-cell analysis integrating spatial proteomic/genomic data, multiplex IHC/FISH/CISH assay development and validation, genomics sequencing and gene expression, flow cytometry for hematopoietic neoplasms and immunophenotyping, and AI-driven digital pathology/image analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Flagship Biosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Anbio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Anbio
2.2 - Growth funds investing in similar companies to Anbio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Anbio
4.2 - Public trading comparable groups for Anbio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →